American Association for the Advancement of Science, Science Translational Medicine, 534(12), 2020
DOI: 10.1126/scitranslmed.aav7431
Export citation
Search in Google Scholar
Show less
Full text: Unavailable
DCs are critical cellular targets of PD-L1 blockade in cancer treatment.